Cell Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Cell Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview:

The global cell analysis market size reached US$ 19.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 31.1 Billion by 2028, exhibiting a growth rate (CAGR) of 8.7% during 2023-2028.

Cell analysis refers to an umbrella term for a wide variety of technologies that are utilized to study genetic and phenotypical characteristics of a cell. Its objective is to gain insights into the mechanisms of cellular functionality that requires an understanding of the cellular components, such as the DNA, RNA, protein content and cellular metabolites. Cell analysis is typically done to understand population heterogeneity, identifying minority sub-populations of interest, as well as discovering unique characteristics of individual cells. It further aids in gene and protein identification, and epigenomics, as well as understanding the factors that underlie cell health, proliferation and death.

Cell analysis is utilized across academic and research laboratories, hospitals, and biotechnology and pharmaceutical, for studying stem cells, immunology, neurology, non-invasive prenatal diagnosis and in-vitro fertilization. Furthermore, the rising prevalence of chronic diseases, along with the development of advanced therapies for the treatment of cancer, are encouraging technological advancements in cell analysis. For instance, Fluidigm Corporation, a US-based company, announced the introduction of a REAP-seq (RNA expression and protein sequencing) that will help researchers to understand the mechanisms of cancer progression and immune response. The increasing investments by governments of several nations in extensive research and development (R&D) activities in the life science sector are acting as another major growth-inducing factor. Other factors, such as the rapid expansion of the biopharmaceutical and biotechnological companies and significant growth in the healthcare industry, are expected to further create a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell analysis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, analysis type, techniques and end-user.

Breakup by Product:

Flow Cytometry Products
qPCR Products
Cell Microarrays
Microscopes
Spectrophotometers
Cell Counters
HCS Systems
Others

Breakup by Analysis Type:

Cell Identification
Cell Viability
Cell Signaling Pathways/Signal Transduction
Cell Proliferation
Cell Counting and Quality Control
Cell Interaction
Target Identification and Validation
Single-Cell Analysis
Others

Breakup by Techniques:

Molecular Approaches
Image-Based Approaches

Breakup by End-User:

Pharmaceutical and Biotechnology Companies and CROs
Hospitals and Diagnostic Laboratories
Research Institutes
Cell Culture Collection Repositories
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., BD Biosciences, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Merck KGaA, Miltenyi Biotec, Olympus Corporation, PerkinElmer Inc., Promega Corporation, Sysmex Corporation, Thermo Fisher Scientific, etc.

Key Questions Answered in This Report

1. What was the size of the global cell analysis market in 2022?
2. What is the expected growth rate of the global cell analysis market during 2023-2028?
3. What are the key factors driving the global cell analysis market?
4. What has been the impact of COVID-19 on the global cell analysis market?
5. What is the breakup of the global cell analysis market based on the product?
6. What is the breakup of the global cell analysis market based on the analysis type?
7. What is the breakup of the global cell analysis market based on the techniques?
8. What is the breakup of the global cell analysis market based on the end-user?
9. What are the key regions in the global cell analysis market?
10. Who are the key players/companies in the global cell analysis market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cell Analysis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Flow Cytometry Products
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 qPCR Products
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cell Microarrays
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Microscopes
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Spectrophotometers
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Cell Counters
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 HCS Systems
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Analysis Type
7.1 Cell Identification
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cell Viability
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cell Signaling Pathways/Signal Transduction
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cell Proliferation
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Cell Counting and Quality Control
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Cell Interaction
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Target Identification and Validation
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Single-Cell Analysis
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Techniques
8.1 Molecular Approaches
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Image-Based Approaches
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End-User
9.1 Pharmaceutical and Biotechnology Companies and CROs
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Diagnostic Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Research Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Cell Culture Collection Repositories
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Agilent Technologies Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 BD Biosciences
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bio-RAD Laboratories Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Danaher Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Illumina Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Merck KGaA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Miltenyi Biotec
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Olympus Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 PerkinElmer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Promega Corporation
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Sysmex Corporation
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Thermo Fisher Scientific
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings